GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Days Sales Outstanding

BioStem Technologies (BioStem Technologies) Days Sales Outstanding : 38.08 (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Days Sales Outstanding?

BioStem Technologies's average Accounts Receivable for the three months ended in Sep. 2023 was $1.50 Mil. BioStem Technologies's Revenue for the three months ended in Sep. 2023 was $3.60 Mil. Hence, BioStem Technologies's Days Sales Outstanding for the three months ended in Sep. 2023 was 38.08.

The historical rank and industry rank for BioStem Technologies's Days Sales Outstanding or its related term are showing as below:

BSEM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.59   Med: 24.49   Max: 2433.33
Current: 74.47

During the past 13 years, BioStem Technologies's highest Days Sales Outstanding was 2433.33. The lowest was 6.59. And the median was 24.49.

BSEM's Days Sales Outstanding is ranked worse than
51.29% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs BSEM: 74.47

BioStem Technologies's Days Sales Outstanding increased from Mar. 2022 (9.85) to Sep. 2023 (38.08).


BioStem Technologies Days Sales Outstanding Historical Data

The historical data trend for BioStem Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Days Sales Outstanding Chart

BioStem Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.07 18.32 6.59 13.12 8.95

BioStem Technologies Quarterly Data
Sep15 Dec15 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.85 - 4.26 10.14 38.08

Competitive Comparison of BioStem Technologies's Days Sales Outstanding

For the Biotechnology subindustry, BioStem Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioStem Technologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's Days Sales Outstanding falls into.



BioStem Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioStem Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.3 + 0.037) / 2 ) / 6.875*365
=0.1685 / 6.875*365
=8.95

BioStem Technologies's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (0.091 + 2.913) / 2 ) / 3.599*365 / 4
=1.502 / 3.599*365 / 4
=38.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioStem Technologies  (OTCPK:BSEM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BioStem Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BioStem Technologies (BioStem Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.